SMAP: sequencing patient-derived xenografts
Transcript of SMAP: sequencing patient-derived xenografts
![Page 1: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/1.jpg)
SMAP: a tool for patient-derived xenografts sequencing data analysis
CIT SÉMINAIRE – 05/10/17
![Page 2: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/2.jpg)
PDX: Patient Derived Xenograft
Stromal cell (mouse)
Tumor cell (human)
PDX Patient Derived Xenograft
Human primary
tumor
![Page 3: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/3.jpg)
Goal
Stromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsRNAseq
![Page 4: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/4.jpg)
Goal
Stromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse reads
HUMAN-tumor Transcriptome or genome
MOUSE-stromaTranscriptome or genome
RNAseq
![Page 5: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/5.jpg)
Existing methods
![Page 6: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/6.jpg)
Existing methods
• Naïve approachHuman Genome
Discarded reads
Kept reads
mapping
![Page 7: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/7.jpg)
Existing methods
• Naïve approachHuman Genome
Discarded reads
Kept reads
Assigned to human
discarded read
mapping
Human Genome Kmer
Mouse Genome Kmer
Read Kmers
• Xenome (Conway et al. 2012)or
Assigned to mouse
![Page 8: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/8.jpg)
Existing methods
• Naïve approachHuman Genome
Discarded reads
Kept reads
mapping
Mouse Genome
Human Genomemapping
mapping
• S3 (Chivukula et al. 2015)
Assigned to mouse
Assigned to human
Ambiguous mapping score comparison
Assigned to human
discarded readHuman
Genome Kmer
Mouse Genome Kmer
Read Kmersor
Assigned to mouse• Xenome (Conway et al. 2012)
![Page 9: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/9.jpg)
SMAP: Overall approach
Stromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsSequencing
HUMAN-tumor Transcriptome or genome
MOUSE-stromaTranscriptome or genome
![Page 10: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/10.jpg)
SMAP: Overall approach
Stromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsSequencing
Mouse Genome Human Genome
Concatenated Genome
+
SMAP
![Page 11: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/11.jpg)
SMAP: Overall approach
Stromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsSequencing
Mouse Genome Human Genome
Concatenated Genome
+
1. SIMULTANEOUS MAPPING ON BOTH GENOMES
2. EVALUATION OF EACH READ’S ALIGNMENTS
SMAP
![Page 12: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/12.jpg)
SMAP: Overall approach
Stromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsSequencing
Mouse Genome Human Genome
Concatenated Genome
+
1. SIMULTANEOUS MAPPING ON BOTH GENOMES
2. EVALUATION OF EACH READ’S ALIGNMENTS
Read assigned to HUMAN
*
*
**
* mismatch
SMAP
![Page 13: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/13.jpg)
SMAP: Overall approach
Stromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsSequencing
Mouse Genome Human Genome
Concatenated Genome
+
1. SIMULTANEOUS MAPPING ON BOTH GENOMES
2. EVALUATION OF EACH READ’S ALIGNMENTS
Read assigned to HUMAN
*
*
**
Read assigned to MOUSE
* *
*
*
* mismatch
SMAP
![Page 14: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/14.jpg)
SMAP: Overall approach
Stromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsSequencing
Mouse Genome Human Genome
Concatenated Genome
+
1. SIMULTANEOUS MAPPING ON BOTH GENOMES
2. EVALUATION OF EACH READ’S ALIGNMENTS
Read assigned to HUMAN
*
*
**
Read assigned to MOUSE
* *
*
*
*
*
Discarded read
* mismatch
SMAP
![Page 15: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/15.jpg)
SMAP: Overall approach
Stromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsSequencing
Mouse Genome Human Genome
Concatenated Genome
+
SMAP
1. SIMULTANEOUS MAPPING ON BOTH GENOMES
2. EVALUATION OF EACH READ’S ALIGNMENTS
Read assigned to HUMAN
*
*
**
Read assigned to MOUSE
* *
*
*
*
*
Discarded read
![Page 16: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/16.jpg)
SMAP: Overall approach
Stromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsSequencing
Mouse Genome Human Genome
Concatenated Genome
+
HUMAN-tumor Transcriptome or genome
MOUSE-stromaTranscriptome or genome
SMAP
1. SIMULTANEOUS MAPPING ON BOTH GENOMES
2. EVALUATION OF EACH READ’S ALIGNMENTS
Read assigned to HUMAN
*
*
**
Read assigned to MOUSE
* *
*
*
*
*
Discarded read
![Page 17: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/17.jpg)
Mapping and specie assignment performance
Read simulation settings*
*fastq simulation using wgsim tool(Escalona et al., 2016)
DirectMapping
Xenome
S3
SMAP
Comparisons
![Page 18: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/18.jpg)
Mapping and specie assignment performance
DirectMapping
Xenome
S3
SMAP
Fals
e P
osit
ives
Tru
e P
osit
ives
Ideal Mutations Mutations
& Errorsideal Mutations Mutations
& Errors
50%
60%
70%
80%
90%
Un
iqu
ely
ma
pp
ed
re
ad
ra
te 50 bp 100 bp
96%
98%
100%
Un
iqu
ely
map
ped
read
rate 50 bp 100 bp
5%
10%
15%
0‰
0.25‰
0.50‰
Ideal Mutations Mutations& Errors
Ideal Mutations Mutations
& Errors
![Page 19: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/19.jpg)
Estimating the impact of inter-specie gene homology
DirectMapping
Xenome
S3
SMAP
Tru
e P
os
itiv
es
50 bp 100 bp
50%
60%
70%
80%
90%
100%
Un
iqu
ely
ma
pp
ed
re
ad
ra
te>95 95-90 90-85 85-80 <80 >95 95-90 90-85 85-80 <80
Identity(in %)
Un
iqu
ely
ma
pp
ed
re
ad
ra
te
Fa
lse
Po
sit
ive
s
10%
20%
30%
40%
0‰
0.25‰
0.50‰
0.75‰
1‰
50 bp 100 bp
>95 95-90 90-85 85-80 <80 >95 95-90 90-85 85-80 <80
Homology
![Page 20: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/20.jpg)
Application to pancreatic cancer xenograft gene expression analysis
Stromal cell (mouse)
Tumor cell (human)PDX Patient Derived Xenograft
Mix of Human and
Mouse reads
RNAseq
HUMAN-tumor Transcriptome or genome
MOUSE-stromaTranscriptome or genome
Pancreatic
Adenocarcinoma
n=30
SMAP
![Page 21: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/21.jpg)
Application to pancreatic cancer xenograft gene expression analysis
Stromal cell (mouse)
Tumor cell (human)PDX Patient Derived Xenograft
Mix of Human and
Mouse reads
RNAseq
HUMAN-tumor Transcriptome or genome
MOUSE-stromaTranscriptome or genome
Pancreatic
Adenocarcinoma
n=30
SMAP
Stroma signalCount matrix
Tumor signalCount matrix
![Page 22: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/22.jpg)
Pathways analysis
PD
AC
001.T
PD
AC
003.T
PD
AC
004.T
PD
AC
005.T
PD
AC
006.T
PD
AC
007.T
PD
AC
008.T
PD
AC
009.T
PD
AC
032.T
PD
AC
011.T
PD
AC
012.T
PD
AC
013.T
PD
AC
014.T
PD
AC
015.T
PD
AC
016.T
PD
AC
017.T
PD
AC
018.T
PD
AC
019.T
PD
AC
020.T
PD
AC
021.T
PD
AC
022.T
PD
AC
023.T
PD
AC
024.T
PD
AC
025.T
PD
AC
026.T
PD
AC
027.T
PD
AC
028.T
PD
AC
029.T
PD
AC
030.T
PD
AC
031.T
PD
AC
001.S
PD
AC
003.S
PD
AC
004.S
PD
AC
005.S
PD
AC
006.S
PD
AC
007.S
PD
AC
008.S
PD
AC
009.S
PD
AC
032.S
PD
AC
011.S
PD
AC
012.S
PD
AC
013.S
PD
AC
014.S
PD
AC
015.S
PD
AC
016.S
PD
AC
017.S
PD
AC
018.S
PD
AC
019.S
PD
AC
020.S
PD
AC
021.S
PD
AC
022.S
PD
AC
023.S
PD
AC
024.S
PD
AC
025.S
PD
AC
026.S
PD
AC
027.S
PD
AC
028.S
PD
AC
029.S
PD
AC
030.S
PD
AC
031.S
CytokeratinsNucleotide excision repairDNA replicationRNA transportCell cycleHomologous recombinationMismatch repairSpliceosomePyrimidine metabolismBase excision repairRibosome biogenesis in eukaryotesRNA degradationUbiquitin mediated proteolysisHistidine metabolismSteroid biosynthesisPeroxisomeGlycerophospholipid metabolismBiosynthesis of unsaturated fatty acidsVitamin digestion and absorption
LysosomeB cell receptor signaling pathwayHematopoietic cell lineageCell adhesion molecules (CAMs)Natural killer cell mediated cytotoxicityChemokine signaling pathwayCytokine-cytokine receptor interactionRegulation of actin cytoskeletonECM-receptor interactionCalcium signaling pathwayLeukocyte transendothelial migrationToll-like receptor signaling pathwayFocal adhesionVascular smooth muscle contraction
Tumor/human Stroma/murine
0.4
0.2
0
-0.2
-0.4
+
-
![Page 23: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/23.jpg)
Pathways analysis
PD
AC
001.T
PD
AC
003.T
PD
AC
004.T
PD
AC
005.T
PD
AC
006.T
PD
AC
007.T
PD
AC
008.T
PD
AC
009.T
PD
AC
032.T
PD
AC
011.T
PD
AC
012.T
PD
AC
013.T
PD
AC
014.T
PD
AC
015.T
PD
AC
016.T
PD
AC
017.T
PD
AC
018.T
PD
AC
019.T
PD
AC
020.T
PD
AC
021.T
PD
AC
022.T
PD
AC
023.T
PD
AC
024.T
PD
AC
025.T
PD
AC
026.T
PD
AC
027.T
PD
AC
028.T
PD
AC
029.T
PD
AC
030.T
PD
AC
031.T
PD
AC
001.S
PD
AC
003.S
PD
AC
004.S
PD
AC
005.S
PD
AC
006.S
PD
AC
007.S
PD
AC
008.S
PD
AC
009.S
PD
AC
032.S
PD
AC
011.S
PD
AC
012.S
PD
AC
013.S
PD
AC
014.S
PD
AC
015.S
PD
AC
016.S
PD
AC
017.S
PD
AC
018.S
PD
AC
019.S
PD
AC
020.S
PD
AC
021.S
PD
AC
022.S
PD
AC
023.S
PD
AC
024.S
PD
AC
025.S
PD
AC
026.S
PD
AC
027.S
PD
AC
028.S
PD
AC
029.S
PD
AC
030.S
PD
AC
031.S
CytokeratinsNucleotide excision repairDNA replicationRNA transportCell cycleHomologous recombinationMismatch repairSpliceosomePyrimidine metabolismBase excision repairRibosome biogenesis in eukaryotesRNA degradationUbiquitin mediated proteolysisHistidine metabolismSteroid biosynthesisPeroxisomeGlycerophospholipid metabolismBiosynthesis of unsaturated fatty acidsVitamin digestion and absorption
LysosomeB cell receptor signaling pathwayHematopoietic cell lineageCell adhesion molecules (CAMs)Natural killer cell mediated cytotoxicityChemokine signaling pathwayCytokine-cytokine receptor interactionRegulation of actin cytoskeletonECM-receptor interactionCalcium signaling pathwayLeukocyte transendothelial migrationToll-like receptor signaling pathwayFocal adhesionVascular smooth muscle contraction
Tumor/human Stroma/murine
0.4
0.2
0
-0.2
-0.4
+
-
![Page 24: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/24.jpg)
Pathways analysis
PD
AC
001.T
PD
AC
003.T
PD
AC
004.T
PD
AC
005.T
PD
AC
006.T
PD
AC
007.T
PD
AC
008.T
PD
AC
009.T
PD
AC
032.T
PD
AC
011.T
PD
AC
012.T
PD
AC
013.T
PD
AC
014.T
PD
AC
015.T
PD
AC
016.T
PD
AC
017.T
PD
AC
018.T
PD
AC
019.T
PD
AC
020.T
PD
AC
021.T
PD
AC
022.T
PD
AC
023.T
PD
AC
024.T
PD
AC
025.T
PD
AC
026.T
PD
AC
027.T
PD
AC
028.T
PD
AC
029.T
PD
AC
030.T
PD
AC
031.T
PD
AC
001.S
PD
AC
003.S
PD
AC
004.S
PD
AC
005.S
PD
AC
006.S
PD
AC
007.S
PD
AC
008.S
PD
AC
009.S
PD
AC
032.S
PD
AC
011.S
PD
AC
012.S
PD
AC
013.S
PD
AC
014.S
PD
AC
015.S
PD
AC
016.S
PD
AC
017.S
PD
AC
018.S
PD
AC
019.S
PD
AC
020.S
PD
AC
021.S
PD
AC
022.S
PD
AC
023.S
PD
AC
024.S
PD
AC
025.S
PD
AC
026.S
PD
AC
027.S
PD
AC
028.S
PD
AC
029.S
PD
AC
030.S
PD
AC
031.S
CytokeratinsNucleotide excision repairDNA replicationRNA transportCell cycleHomologous recombinationMismatch repairSpliceosomePyrimidine metabolismBase excision repairRibosome biogenesis in eukaryotesRNA degradationUbiquitin mediated proteolysisHistidine metabolismSteroid biosynthesisPeroxisomeGlycerophospholipid metabolismBiosynthesis of unsaturated fatty acidsVitamin digestion and absorption
LysosomeB cell receptor signaling pathwayHematopoietic cell lineageCell adhesion molecules (CAMs)Natural killer cell mediated cytotoxicityChemokine signaling pathwayCytokine-cytokine receptor interactionRegulation of actin cytoskeletonECM-receptor interactionCalcium signaling pathwayLeukocyte transendothelial migrationToll-like receptor signaling pathwayFocal adhesionVascular smooth muscle contraction
Tumor/human Stroma/murine
Cell cycle
0.4
0.2
0
-0.2
-0.4
+
-
![Page 25: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/25.jpg)
Pathways analysis
PD
AC
001.T
PD
AC
003.T
PD
AC
004.T
PD
AC
005.T
PD
AC
006.T
PD
AC
007.T
PD
AC
008.T
PD
AC
009.T
PD
AC
032.T
PD
AC
011.T
PD
AC
012.T
PD
AC
013.T
PD
AC
014.T
PD
AC
015.T
PD
AC
016.T
PD
AC
017.T
PD
AC
018.T
PD
AC
019.T
PD
AC
020.T
PD
AC
021.T
PD
AC
022.T
PD
AC
023.T
PD
AC
024.T
PD
AC
025.T
PD
AC
026.T
PD
AC
027.T
PD
AC
028.T
PD
AC
029.T
PD
AC
030.T
PD
AC
031.T
PD
AC
001.S
PD
AC
003.S
PD
AC
004.S
PD
AC
005.S
PD
AC
006.S
PD
AC
007.S
PD
AC
008.S
PD
AC
009.S
PD
AC
032.S
PD
AC
011.S
PD
AC
012.S
PD
AC
013.S
PD
AC
014.S
PD
AC
015.S
PD
AC
016.S
PD
AC
017.S
PD
AC
018.S
PD
AC
019.S
PD
AC
020.S
PD
AC
021.S
PD
AC
022.S
PD
AC
023.S
PD
AC
024.S
PD
AC
025.S
PD
AC
026.S
PD
AC
027.S
PD
AC
028.S
PD
AC
029.S
PD
AC
030.S
PD
AC
031.S
CytokeratinsNucleotide excision repairDNA replicationRNA transportCell cycleHomologous recombinationMismatch repairSpliceosomePyrimidine metabolismBase excision repairRibosome biogenesis in eukaryotesRNA degradationUbiquitin mediated proteolysisHistidine metabolismSteroid biosynthesisPeroxisomeGlycerophospholipid metabolismBiosynthesis of unsaturated fatty acids
LysosomeB cell receptor signaling pathwayHematopoietic cell lineageCell adhesion molecules (CAMs)Natural killer cell mediated cytotoxicityChemokine signaling pathwayCytokine-cytokine receptor interactionRegulation of actin cytoskeletonECM-receptor interactionCalcium signaling pathwayLeukocyte transendothelial migrationToll-like receptor signaling pathwayFocal adhesionVascular smooth muscle contraction
Tumor/human Stroma/murine
Vitamin digestion and absorption
0.4
0.2
0
-0.2
-0.4
+
-
![Page 26: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/26.jpg)
Pathways analysis
PD
AC
001.T
PD
AC
003.T
PD
AC
004.T
PD
AC
005.T
PD
AC
006.T
PD
AC
007.T
PD
AC
008.T
PD
AC
009.T
PD
AC
032.T
PD
AC
011.T
PD
AC
012.T
PD
AC
013.T
PD
AC
014.T
PD
AC
015.T
PD
AC
016.T
PD
AC
017.T
PD
AC
018.T
PD
AC
019.T
PD
AC
020.T
PD
AC
021.T
PD
AC
022.T
PD
AC
023.T
PD
AC
024.T
PD
AC
025.T
PD
AC
026.T
PD
AC
027.T
PD
AC
028.T
PD
AC
029.T
PD
AC
030.T
PD
AC
031.T
PD
AC
001.S
PD
AC
003.S
PD
AC
004.S
PD
AC
005.S
PD
AC
006.S
PD
AC
007.S
PD
AC
008.S
PD
AC
009.S
PD
AC
032.S
PD
AC
011.S
PD
AC
012.S
PD
AC
013.S
PD
AC
014.S
PD
AC
015.S
PD
AC
016.S
PD
AC
017.S
PD
AC
018.S
PD
AC
019.S
PD
AC
020.S
PD
AC
021.S
PD
AC
022.S
PD
AC
023.S
PD
AC
024.S
PD
AC
025.S
PD
AC
026.S
PD
AC
027.S
PD
AC
028.S
PD
AC
029.S
PD
AC
030.S
PD
AC
031.S
CytokeratinsNucleotide excision repairDNA replicationRNA transportCell cycleHomologous recombinationMismatch repairSpliceosomePyrimidine metabolismBase excision repairRibosome biogenesis in eukaryotesRNA degradationUbiquitin mediated proteolysisHistidine metabolismSteroid biosynthesisPeroxisomeGlycerophospholipid metabolismBiosynthesis of unsaturated fatty acidsVitamin digestion and absorption
B cell receptor signaling pathwayHematopoietic cell lineage
Natural killer cell mediated cytotoxicityCytokine-cytokine receptor interactionRegulation of actin cytoskeletonECM-receptor interaction
Leukocyte transendothelial migrationToll-like receptor signaling pathwayFocal adhesionVascular smooth muscle contraction
Tumor/human Stroma/murine
0.4
0.2
0
-0.2
-0.4
+
-
![Page 27: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/27.jpg)
Immune populations (MCPcounter tool, Becht et al. 2016)
CD8 T cells
Cytotoxic lymphocytes
T cells
NK cells
B lineage
Neutrophils
Monocytic lineage
Endothelial cells
Fibroblasts
PD
AC
00
1.T
PD
AC
00
3.T
PD
AC
00
4.T
PD
AC
00
5.T
PD
AC
00
6.T
PD
AC
00
7.T
PD
AC
00
8.T
PD
AC
00
9.T
PD
AC
03
2.T
PD
AC
01
1.T
PD
AC
01
2.T
PD
AC
01
3.T
PD
AC
01
4.T
PD
AC
01
5.T
PD
AC
01
6.T
PD
AC
01
7.T
PD
AC
01
8.T
PD
AC
01
9.T
PD
AC
02
0.T
PD
AC
02
1.T
PD
AC
02
2.T
PD
AC
02
3.T
PD
AC
02
4.T
PD
AC
02
5.T
PD
AC
02
6.T
PD
AC
02
7.T
PD
AC
02
8.T
PD
AC
02
9.T
PD
AC
03
0.T
PD
AC
03
1.T
PD
AC
00
1.S
PD
AC
00
3.S
PD
AC
00
4.S
PD
AC
00
5.S
PD
AC
00
6.S
PD
AC
00
7.S
PD
AC
00
8.S
PD
AC
00
9.S
PD
AC
03
2.S
PD
AC
01
1.S
PD
AC
01
2.S
PD
AC
01
3.S
PD
AC
01
4.S
PD
AC
01
5.S
PD
AC
01
6.S
PD
AC
01
7.S
PD
AC
01
8.S
PD
AC
01
9.S
PD
AC
02
0.S
PD
AC
02
1.S
PD
AC
02
2.S
PD
AC
02
3.S
PD
AC
02
4.S
PD
AC
02
5.S
PD
AC
02
6.S
PD
AC
02
7.S
PD
AC
02
8.S
PD
AC
02
9.S
PD
AC
03
0.S
PD
AC
03
1.S
Tumor/human Stroma/murine
2 1 0 -1 -2
![Page 28: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/28.jpg)
SMAP: Overall approach
SMAPStromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsSequencing
Mouse Genome Human Genome
Concatenated Genome
+
1. SIMULTANEOUS MAPPING ON BOTH GENOMES
2. EVALUATION OF EACH READ’S ALIGNMENTS
Read assigned to HUMAN
*
*
**
Read assigned to MOUSE
* *
*
*
*
*
Discarded read
* mismatch
HUMAN-tumor Transcriptome or genome
MOUSE-stromaTranscriptome or genome
![Page 29: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/29.jpg)
SMAP: Overall approach
SMAPStromal cell (mouse)
Tumor cell (human)PDX
Patient Derived Xenograft
Mix of Human and
Mouse readsSequencing
Mouse Genome Human Genome
Concatenated Genome
+
1. SIMULTANEOUS MAPPING ON BOTH GENOMES
2. EVALUATION OF EACH READ’S ALIGNMENTS
Read assigned to HUMAN
*
*
**
Read assigned to MOUSE
* *
*
*
*
*
Discarded read
* mismatch
HUMAN-tumor Transcriptome or genome
MOUSE-stromaTranscriptome or genome
SMAP-fuzSMAP-fuz
![Page 30: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/30.jpg)
SMAP-fuz: Fusion detection strategy
Spurious fusions (human-
murine fusions)
Spanning: null distribution(Negative binomial)
Junction: null distribution (Negative Binomial)
human-human fusions
RAW FUSIONS
P-value for each human-
human fusion spanning count
P-value for each human-
human fusion junction count
• Combining P-value
• FDR correction
![Page 31: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/31.jpg)
50bp 100bp
0
200400
Nu
mb
er
of
fus
ion
s
Fusion detection performance
Read and fusions simulation settings
• 50M reads human
transcriptome
• 20M reads mouse
transcriptome
• 500 000 from 100 simulated
human fusions transcripts.
Reads were simulated using the Mutations rate 0.01 and errors 0.1 %
100
TotTPFP
FN
![Page 32: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/32.jpg)
Application to pancreatic cancer xenograft gene expression analysis
0%
5%
10%
15%
all
STAR-Fusion
fdr 5% fdr 1% fdr 0.1%
Fa
lse
Fu
sio
ns
(in
%)*
STAR_Fusion + SMAP-fuz
filter
Pancreatic
Adenocarcinoma
n=30
*inter-specie fusions
![Page 33: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/33.jpg)
SMAP on Github https://remynicolle.github.io/SMAP/
![Page 34: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/34.jpg)
![Page 35: SMAP: sequencing patient-derived xenografts](https://reader030.fdocuments.us/reader030/viewer/2022012022/6169c80211a7b741a34b4a38/html5/thumbnails/35.jpg)
Sup. Info